{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:11:51Z","timestamp":1761174711319,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4108,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1046\/j.1469-0691.2003.00775.x","type":"journal-article","created":{"date-parts":[[2003,9,17]],"date-time":"2003-09-17T12:47:18Z","timestamp":1063802838000},"page":"984-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare"],"prefix":"10.1016","volume":"9","author":[{"given":"M.E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.A.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Draghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.F.","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Porschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Patra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.G.","family":"DelVecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00775.x_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib2","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/AAC.46.7.2307-2309.2002","article-title":"Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000","volume":"46","author":"Cavallo","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.44.6.1766-1766.2000","article-title":"In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne","volume":"44","author":"Choe","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0924-8579(01)00464-2","article-title":"In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones","volume":"18","author":"Brook","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib5","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"1","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0923-2508(02)01299-8","article-title":"Variation of rRNA operon number as revealed by ribotyping of Bacillus anthracis strains","volume":"153","author":"Patra","year":"2002","journal-title":"Res Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib7","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1128\/JCM.36.11.3412-3414.1998","article-title":"Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997","volume":"36","author":"Patra","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib8","series-title":"Manual of clinical microbiology","first-page":"349","article-title":"Bacillus","author":"Turnbull","year":"1995"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.1996.tb08548.x","article-title":"Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA","volume":"145","author":"Ramisse","year":"1996","journal-title":"FEMS Microbiol Lett"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1099\/jmm.0.05027-0","article-title":"Identification of Bacillus anthracis by a simple protective antigen-specific mAb dot-ELISA","volume":"52","author":"Sastry","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib11","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/JB.182.10.2928-2936.2000","article-title":"Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis","volume":"182","author":"Keim","year":"2000","journal-title":"J Bacteriol"},{"year":"2002","series-title":"Performance standards for antimicrobial susceptibility testing; Twelfth Informational Supplement. M100-S12","author":"National Committee for Clinical Laboratory Standards","key":"10.1046\/j.1469-0691.2003.00775.x_bib12"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib13","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/JCM.40.6.1902-1907.2002","article-title":"Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods","volume":"40","author":"Mohammed","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib14","first-page":"909","article-title":"Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365549109024319","article-title":"Antimicrobial susceptibility of Bacillus anthracis","volume":"23","author":"Doganay","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00775.x_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/00221287-139-3-601","article-title":"A macrolide\u2013lincosamide\u2013streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ","volume":"139","author":"Kim","year":"1993","journal-title":"J Gen Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14630536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14630536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:17:08Z","timestamp":1761117428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14630536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S1198743X14630536"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00775.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00775.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}